A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

This study has been terminated.
(This study was stopped 20 May 2010 due to strategic considerations)
Information provided by (Responsible Party):
Abbott ( Abbott Products )
ClinicalTrials.gov Identifier:
First received: November 30, 2007
Last updated: September 9, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 9, 2011